A Study to Test Different Doses of BI 1831169 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors)

PHASE1RecruitingINTERVENTIONAL
Enrollment

190

Participants

Timeline

Start Date

March 28, 2022

Primary Completion Date

December 13, 2027

Study Completion Date

October 31, 2028

Conditions
Solid Tumors
Interventions
DRUG

BI 1831169

BI 1831169

DRUG

anti-PD-1 antibody

anti-PD-1 antibody

Trial Locations (40)

1205

NOT_YET_RECRUITING

University Hospital Geneva, Geneva

2650

RECRUITING

Edegem - UNIV UZ Antwerpen, Edegem

3000

NOT_YET_RECRUITING

UZ Leuven, Leuven

3010

NOT_YET_RECRUITING

University Hospital Bern/Inselspital Bern, Bern

3199

NOT_YET_RECRUITING

Peninsula Haematology & Oncology, Frankston

5020

NOT_YET_RECRUITING

Salzburg Cancer Research Institute, Salzburg

5062

NOT_YET_RECRUITING

Southern Oncology Clinical Research Unit, Bedford Park

6020

RECRUITING

Medical University of Innsbruck, Innsbruck

9000

NOT_YET_RECRUITING

UNIV UZ Gent, Ghent

10060

NOT_YET_RECRUITING

Istituto Di Candiolo, Candiolo (TO)

12203

NOT_YET_RECRUITING

Charite Universitätsmedizin Berlin KöR, Berlin

13385

RECRUITING

HOP Timone, Marseille

20162

NOT_YET_RECRUITING

ASST Grande Ospedale Metropolitano Niguarda, Milan

27157

RECRUITING

Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem

28040

RECRUITING

Fundación Jiménez Díaz, Madrid

29605

NOT_YET_RECRUITING

Prisma Health, Greenville

30322

NOT_YET_RECRUITING

Winship Cancer Institute, Atlanta

31008

RECRUITING

Clínica Universidad de Navarra, Pamplona

32806

RECRUITING

Orlando Health Cancer Institute, Orlando

33000

RECRUITING

INS Bergonie, Bordeaux

33136

NOT_YET_RECRUITING

University of Miami, Miami

35042

RECRUITING

CTR Eugène Marquis, Rennes

37126

NOT_YET_RECRUITING

Azienda Ospedaliera Universitaria Integrata Verona, Verona

40202

NOT_YET_RECRUITING

University of Louisville, Louisville

46009

NOT_YET_RECRUITING

Instituto Valenciano de Oncología, Valencia

55455

RECRUITING

M Health Fairview University of Minnesota Medical Center, Minneapolis

69120

NOT_YET_RECRUITING

Universitätsklinikum Heidelberg, Heidelberg

72076

RECRUITING

Universitätsklinikum Tübingen, Tübingen

77030

RECRUITING

The University of Texas MD Anderson Cancer Center, Houston

80045

RECRUITING

University of Colorado Denver, Aurora

85234

RECRUITING

Banner MD Anderson Cancer Center-Gilbert-55251, Gilbert

85719

NOT_YET_RECRUITING

University of Arizona, Tucson

89081

RECRUITING

Universitätsklinikum Ulm, Ulm

90404

RECRUITING

Providence St. John's Health Center, Santa Monica

92037

NOT_YET_RECRUITING

University of California San Diego, La Jolla

94805

RECRUITING

INS Gustave Roussy, Villejuif

07960

RECRUITING

Morristown Medical Center, Morristown

M5G 2M9

NOT_YET_RECRUITING

Princess Margaret Cancer Centre, Toronto

08023

NOT_YET_RECRUITING

Hospital Quiron. I.C.U., Barcelona

08907

RECRUITING

Hospital Duran i Reynals, L'Hospitalet de Llobregat

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT05155332 - A Study to Test Different Doses of BI 1831169 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors) | Biotech Hunter | Biotech Hunter